Speakers

 

Sally Alexander, Clinical Nurse Specialist, Massachusetts General Hospital

Sally Alexander | Clinical Nurse Specialist | Massachusetts General Hospital » speaking at Advanced Therapies

Omar Aljitawi, Associate Professor, University of Rochester Medical Center

Sean Armour, Head of Discovery, Spark Therapeutics

Fausto Artico, Global R&D Tech Head of Innovation and Data Science, GSK

Michael Baker, Senior Director Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies

Alessia Baldo, business development manager, SEED Biosciences

Alessia Baldo | business development manager | SEED Biosciences » speaking at Advanced Therapies

Tomasz Baran, Executive VP, PBKM/FamiCord Group

Tomasz Baran | Executive VP | PBKM/FamiCord Group » speaking at Advanced Therapies

Colin Barker, CSO, BiologIC Technologies

Roy Baynes, Senior Vice President Clinical Research, Merck Research Laboratories

Tim Bertram, Chief Executive Officer, ProKidney

Bastiaan Bijl, Business Development Director, Single Cell Discoveries

Bastiaan Bijl | Business Development Director | Single Cell Discoveries » speaking at Advanced Therapies

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Jaap Boelens, Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

James Bonham, President, International Society for Neonatal Screening

Luis Borges, CSO, Century Therapeutics

PJ Brooks, Health Scientist Administrator, NIH/NCATS

Mr Philip J. Brooks, Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Julien Browne, Head of Analytical Development, Quell Therapeutics

Julien Browne | Head of Analytical Development | Quell Therapeutics » speaking at Advanced Therapies

Didier Caizergues, Head of regulatory affairs department, Genethon

Heather Callahan, Director of Licensing, University of Colorado

Emmanuelle Cameau, Strategic Technology Partnership Leader, Pall Corp

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Manuel Carrondo | Professor | iBET: Instituto de Biologia Experimental e Tecnológica » speaking at Advanced Therapies

Paul S Carter, Director, Head Vector Processing, Quell Therapeutics

Paul S Carter | Director, Head Vector Processing | Quell Therapeutics » speaking at Advanced Therapies

Pedro Cejas, Discovery Lead, Spark Therapeutics

Pedro Cejas | Discovery Lead | Spark Therapeutics » speaking at Advanced Therapies

Philippe Chambon, Chairman & Chief Executive Officer, EG 427

Philippe Chambon | Chairman & Chief Executive Officer | EG 427 » speaking at Advanced Therapies

Pascale Charbonnel, Business Development, SCT Bio

Poulami Chaudhuri, Co-Founder & Chief Executive Officer, Helex Bio

Poulami Chaudhuri | Co-Founder & Chief Executive Officer | Helex Bio » speaking at Advanced Therapies

Jonathan Cheng, Senior Vice President, Bristol Myers Squibb

Jonathan Cheng | Senior Vice President | Bristol Myers Squibb » speaking at Advanced Therapies

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Klaus Cichutek, President, Paul Ehrlich Institute

Rodolphe Clerval, Chief Executive Officer, Coave Therapeutics

Selim Corbacioglu, Department Chair, Universoty Medical Center Regensburg

Selim Corbacioglu | Department Chair | Universoty Medical Center Regensburg » speaking at Advanced Therapies

Yemisi Corinaldi, Regulatory Strategy Leader, Spark Therapeutics UK Limited

Yemisi Corinaldi | Regulatory Strategy Leader | Spark Therapeutics UK Limited » speaking at Advanced Therapies

Pedro Correa de Sampaio, Chief Executive Officer, Neobe Therapeutics

Pedro Correa de Sampaio | Chief Executive Officer | Neobe Therapeutics » speaking at Advanced Therapies

Vicki Coutinho, VP Regulatory Affairs, Gammadelta Therapeutics

Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center

Conrad Russell Y Cruz | Assistant Professor, Children's National Medical Center; Co-Founder | Children's National Medical Center » speaking at Advanced Therapies

Derek Dashti, Founder And Chief Executive Officer, D and P Bioinnovations

Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy

Anna David, Professor and Consultant in Obstetrics and Maternal Fetal Medicine; Director, EGA Institute for Women's Health,, University College London

Anna David | Professor and Consultant in Obstetrics and Maternal Fetal Medicine; Director, EGA Institute for Women's Health, | University College London » speaking at Advanced Therapies

Ian Davies, Business Consultant, Digital Lab Consulting

Freddie Dear, Partner, Syncona

Tyler DeWitt, Executive Director, Innovation, Quality Executive Partners, Inc.

Jean-Simon Diallo, Chief Executive Officer, Virica Biotech

Jean-Simon Diallo | Chief Executive Officer | Virica Biotech » speaking at Advanced Therapies

Jakob Dupont, EVP, Head of Global Research & Development, Atara Biotherapeutics

Mélodie Dupré, Business Development, Genethon

Mélodie Dupré | Business Development | Genethon » speaking at Advanced Therapies

Florian Eichler, Associate Professor of Neurology, Massachusetts General Hospital

Tim Eisen, Franchise Head, GU Oncology, Roche

Victoria English, Co-Founder And Editor, Evernow Publications

Gina Ewy, Market Access, Hansa Biopharma

Gina Ewy | Market Access | Hansa Biopharma » speaking at Advanced Therapies

MARCO FADDA, ATMP Solutions Manager, Comecer

Luka Fajs, Business Development, Bio-ReCell

Suzanne Farid, Professor of Bioprocess Systems Engineering & Co-Director Future Targeted Healthcare Manufacturing Hub, University College London

Mick Fellows, Director CVRM Cell Therapy Safety Clinical Pharmacology and Safety Sciences, AstraZeneca

Marcie Finney, Executive Director, Cleveland Cord Blood Center

Marcie Finney | Executive Director | Cleveland Cord Blood Center » speaking at Advanced Therapies

Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics

Joan Fitzgerald, Research Fellow, Calin Project, Regenerative Medicine Institute (REMEDI), National University of Ireland Galway

David Fontana, Team leader, Umoja Biopharma

David Fontana | Team leader | Umoja Biopharma » speaking at Advanced Therapies

Miguel Forte, Chief Executive Officer, Bone Therapeutics

Mike Fraser, Head of EMEA Region, Novartis Gene Therapies

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Sapan Gandhi, Founder, Drishti Discoveries

Sapan Gandhi | Founder | Drishti Discoveries » speaking at Advanced Therapies

Javier Garcia, Chief Executive Officer, Viralgen Vector Core

André Gerth, Chief Executive Officer, FamiCord Deutschland GmbH

Daniel Getts, Co-founder & Chief Executive Officer, Myeloid Therapeutics

Chiara Giacomini, Research Associate, King's College London

Chiara Giacomini | Research Associate | King's College London » speaking at Advanced Therapies

Lenart Girandon, Chief Executive Officer, Educell

Paul Gissen, Professor of Metabolic Medicine, Head of Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health

Janet Glassford, Senior Quality Assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | Senior Quality Assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Simon Goldman, Investment Director, Albion Capital

Cecilia Gotherstrom, Research Leader And Associate Professor, Karolinska Institutet

Roberto Gramignoli, Sr Researcher, Karolinska Institutet

David Greenwald, Vice President Of Business Development, Deerfield Management

David Greenwald | Vice President Of Business Development | Deerfield Management » speaking at Advanced Therapies

Miriam Haak, Director Business Development, Miltenyi Biotec B.V.&Co. KG

Patrick J Hanley, Chief and Director, Cellular Therapy Program, Children's National Medical Center

Rafiq Hasan, Chief Executive Officer, Complement Therapeutics

Rafiq Hasan | Chief Executive Officer | Complement Therapeutics » speaking at Advanced Therapies

Hansjorg Hauser, Head of Department Gene Regulation and Differentiation, Helmholtz Centre for Infection Research GmbH

Amir Hefni, VP, Global Commercial Head, Cell & Gene, Novartis

Dawn Henke, Senior Scientific Program Manager, Standards Coordinating Body

Laura Herbst, Research Fellow, Fraunhofer-Institute for Production Technology

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Tony Hitchcock, Technical Director, Cell and Gene Therapy CDMO, Charles River Laboratories

Simon Hollingsworth, VP, Global Product Leader – Lynparza, AstraZeneca

Greg Hopkins, Associate Manager/Scientist, Analytical Development Group, 2seventy Bio

Roger Horton, Cell and Gene Therapies Clinical Delivery Lead, Anthony Nolan

Volker Huppert, Chief Development Officer, Glycostem Therapeutics BV

Farid Ighemat, Senior Director Cell and Gene Therapy, GlaxoSmithKline

Farid Ighemat | Senior Director Cell and Gene Therapy | GlaxoSmithKline » speaking at Advanced Therapies

Adam Inche, Founder, Lentitek

Adam Inche | Founder | Lentitek » speaking at Advanced Therapies

Moshe Israeli, Medical Director, Rabin Medical Center

Moshe Israeli | Medical Director | Rabin Medical Center » speaking at Advanced Therapies

Basma Jeelani, Head, Business and Innovation Group, University College London

Elizabeth Johnson, Co-founder, National Association of Medication Access & Patient Advocacy

Kamar Johnson, Business Development Director, Europe, TrakCel Ltd

Mr Anthony Johnson, CEO/ President, Kodikaz

Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics

Ron Jortner, Managing Director, Masthead Biosciences

Ron Jortner | Managing Director | Masthead Biosciences » speaking at Advanced Therapies

Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma

Ms Catherine Joynson, Assistant Director, Nuffield Council On Bioethics

Rajvinder Karda, Group Lead, University College London

Ohad Karnieli, Founder & CEO, ADVA Biotechnology

Cornelia kasper, professor, boku

Jasmin Kee, Bioprocessing Consultant and Former Technical Director, UK Gov Vaccines Taskforce

Jasmin Kee | Bioprocessing Consultant and Former Technical Director | UK Gov Vaccines Taskforce » speaking at Advanced Therapies

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Aisha Khan, Executive Director Of Lab Operations At The Interdisciplinary Stem Cell Institute, Miller School of Medicine University of Miami

Sven Kili, Chief Executive Officer, Antion Biosciences

Sven Kili | Chief Executive Officer | Antion Biosciences » speaking at Advanced Therapies

Lucia Kirchgeorg, Director Business Development, Rentschler Biopharma

Hans Kleine-Brüggeney, CTO & Co-Founder, evorion biotechnologies

Hans Kleine-Brüggeney | CTO & Co-Founder | evorion biotechnologies » speaking at Advanced Therapies

Michael Klichinsky, Co-Founder, Vice President Of Discovery And Research, Carisma Therapeutics

Laura Koivusalo, Chief Executive Officer & Founder, StemSight

Laura Koivusalo | Chief Executive Officer & Founder | StemSight » speaking at Advanced Therapies

Joanne Kurtzberg, Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures,, Duke University Medical Center

James Kusena, Head of Bioprocessing, MicrofluidX

James Kusena | Head of Bioprocessing | MicrofluidX » speaking at Advanced Therapies

Matthew Lakelin, VP Scientific Affairs, TrakCel

Lawrence Lamb, Executive Vice President And Chief Scientific Officer, in8bio

Dorothea Ledergerber, CTO, Tigen

Dorothea Ledergerber | CTO | Tigen » speaking at Advanced Therapies

Michael Leek, Chief Executive Officer, TC BioPharm

Dan Lewi, Chief Executive Officer, Cure & Action Tay-Sachs (CATS) Foundation

Mark Lowdell, CSO/CMO, INmuneBio

Frank Luyten, Medical/Scientific Director, RegMed XB

Ross Macdonald, CEO, Cynata Therapeutics Ltd

John Maher, CSO, Leucid Bio

David Main, President & Chief Executive Officer, Notch Therapeutics

David Main | President & Chief Executive Officer | Notch Therapeutics » speaking at Advanced Therapies

Rey Mali, VP of Sales and Marketing, Accellix Inc

Severine Marconi, Senior Director for EU Regulatory Affairs, AskBio

Severine Marconi | Senior Director for EU Regulatory Affairs | AskBio » speaking at Advanced Therapies

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Paolo Martini, Chief Scientific Officer, Rare Diseases, Moderna Therapeutics

Yoshiaki Maruyama, Review Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Allison Matthews, Service Designer, Mayo Clinic Center for Innovation

Allison Matthews | Service Designer | Mayo Clinic Center for Innovation » speaking at Advanced Therapies

Imen Mestiri, business development manager, Genethon

Imen Mestiri | business development manager | Genethon » speaking at Advanced Therapies

Raymond Miller, Lead of Global Product Management Team 1, GenScript

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics

James Miskin, Chief Technical Officer, Oxford Biomedica

Deana Mohr, Chief Executive Officer & Co-Founder, MUVON Therapeutics

Deana Mohr | Chief Executive Officer & Co-Founder | MUVON Therapeutics » speaking at Advanced Therapies

Bruno Montanari, Partner, Seroba Life Sciences

Bruno Montanari | Partner | Seroba Life Sciences » speaking at Advanced Therapies

Felix Montero Julian, Scientific Director, Biomerieux INC

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

david morrow, scientific program manager, EATRIS

Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at Advanced Therapies

Georges Muller, Chief Executive Officer And Co-Founder, SEED Biosciences

Georges Muller | Chief Executive Officer And Co-Founder | SEED Biosciences » speaking at Advanced Therapies

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Snehal Naik, Regulatory Strategy and Policy leader, Spark Therapeutics

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at Advanced Therapies

Timothy Newton, Chief Executive Officer, Reflection Therapeutics

Sarfaraz Niazi, Professor, University of Illinois

Sarfaraz Niazi | Professor | University of Illinois » speaking at Advanced Therapies

Peter Olagunju, Chief Technology Officer, TCR² Therapeutics

Peter Olagunju | Chief Technology Officer | TCR² Therapeutics » speaking at Advanced Therapies

Andreas Olpeter, Vice President Of Sales And Business Development Healthcare, Arvato Supply Chain Solutions

Daniel O'Mahony, Partner, Seroba Life Sciences

Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)

Paul Orchard, Professor of Pediatrics, University of Minnesota

Mareike Ostertag, Global Head, Policy Strategy, Novartis Pharma AG

Jose Manuel (Manny) Otero, Chief Technology Officer and Executive Team Member, Turnstone Biologics

Lylia Ouboussad, Senior Scientist, Quell Therapeutics

Lylia Ouboussad | Senior Scientist | Quell Therapeutics » speaking at Advanced Therapies

Detlev Parow, Previous Head Pharmaceutical Department, DAK-Gesundheit

Detlev Parow | Previous Head Pharmaceutical Department | DAK-Gesundheit » speaking at Advanced Therapies

Shabnum Patel, Associate Director, Process Development & Manufacturing, Center for Cancer Cell Therapy, Stanford Cancer Institute

Krisha Patel, partner, Assurea LLC

Krisha Patel | partner | Assurea LLC » speaking at Advanced Therapies

Joe Payne, Founder, President & Chief Executive Officer, Arcturus Therapeutics

Seren Phillips, Senior Director, EMEA Health Economics and Outcomes Research, Real World Evidence and Market Access, Novartis Gene Therapies

Nancy Pick, Implementation Coordinator, Mayo Clinic

Nancy Pick | Implementation Coordinator | Mayo Clinic » speaking at Advanced Therapies

Nina Pinwill, Head of Commercial Operations, NHS England

Matthew Porteus, Associate Director, Definitive And Curative Medicine, Stanford University

Johan Prevot, Executive Director, IPOPI

Qasim Rafiq, Associate Professor in Cell and Gene Therapy Bioprocess Engineering, University College London

Ahad Rahim, Professor of Translational Neuroscience & Head of Research Department of Pharmacology, University College London

Lior Raviv, Vice President, Development & Operations, Pluristem Therapeutics

Nicola Redfern, Gene Therapy Commercial Market Access Leader, (Ex General Manager, UK, bluebird bio), Independent

Paulo Refinetti, Founder And Chief Executive Officer, Rem Analytics

Paulo Refinetti | Founder And Chief Executive Officer | Rem Analytics » speaking at Advanced Therapies

Albert Ribickas, BMT Manager, Moffitt Cancer Center

Albert Ribickas | BMT Manager | Moffitt Cancer Center » speaking at Advanced Therapies

Thomas Robert, Product Manager, Univercells Technologies

Thomas Robert | Product Manager | Univercells Technologies » speaking at Advanced Therapies

Andre Roeder, Head Global Market Access, TETEC AG

Andre Roeder | Head Global Market Access | TETEC AG » speaking at Advanced Therapies

David Edward Rose, Business Development And Sales Associate, Rare Revolution

David Edward Rose | Business Development And Sales Associate | Rare Revolution » speaking at Advanced Therapies

Holger A Russ, Assistant Professor of Pediatrics, University of Colorado

Even Rustad, Researcher, Oslo University Hospital

Tara Sadeghi, EVP and Head of Operations, Cellenkos

Sumona (Fed) Sarkar, Biomedical Engineer, NIST USA

Sumona (Fed) Sarkar | Biomedical Engineer | NIST USA » speaking at Advanced Therapies

Dominic Schmidt, General Partner, Advent Life Sciences

Tanya Sharma, Chief Executive Officer, Assurea LLC

Tanya Sharma | Chief Executive Officer | Assurea LLC » speaking at Advanced Therapies

Owen Smith, Investment Director, 4BIO Capital

Owen Smith | Investment Director | 4BIO Capital » speaking at Advanced Therapies

Devyn Smith, Chief Executive Officer, Arbor Biotechnologies

Mangala Srinivas, CSO, Cenya Imaging; Chair Group Leader,, Wageningen University and Research Centre

Joseph Stavas, Senior Vice President of Clinical Development, ProKidney

Harald Stover, Allarta Life Science Inc.

Harald Stover |  | Allarta Life Science Inc. » speaking at Advanced Therapies

Stephen Sullivan, Program Manager, Global Alliance for iPSC Therapies (GAiT)

Mathias Svahn, Chief Executive Officer, NextCell Pharma

Magali Taiel, Chief Medical Officer, GenSight Biologics

Paul Peter Tak, President & Chief Executive Officer, Candel Therapeutics

Stefanos Theoharis, Chief Business Officer, Bone Therapeutics

IVO TIMMERMANS, Chief Executive Officer, Pleco Therapeutics

IVO TIMMERMANS | Chief Executive Officer | Pleco Therapeutics » speaking at Advanced Therapies

Yatindra Tirunagari, Head of Process Development, Rentschler Biopharma SE

Pamela Tranter, Head, Translational Research Group, Translational Research Office, University College London

Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence

Mark Veich, Executive Director, Deerfield Partnership Foundation and Vice President Deerfield Management, Deerfield Management

Richard Velacott, Chief Executive Officer, BiologIC Technologies

Richard Velacott | Chief Executive Officer | BiologIC Technologies » speaking at Advanced Therapies

David Venables, Chief Executive Officer, Skylark Therapeutics

David Venables | Chief Executive Officer | Skylark Therapeutics » speaking at Advanced Therapies

Frances Verter, Chief Executive Officer, Parent's Guide to Cord Blood Foundation

Frances Verter | Chief Executive Officer | Parent's Guide to Cord Blood Foundation » speaking at Advanced Therapies

Simon Waddington, Professor of Gene Therapy, UCL

Ben Weil, Head of GMP Process Engineering, Royal Free London NHS Foundation Trust

Sue Williams, Managing Director Supply Chain & Operations (& Former Head of Supply Chain at UK Gov Vaccines Taskforce), Hexagon Constultants Ltd.

Bodil Willumsen, Head of EU Supplier Relationship Team, Cell & Gene Technical Operations, Novartis Pharma AG

Tom Wilton, Chief Business Officer, Carisma Therapeutics

Simon Young, Director, RDCUK, Sysmex

Elisabetta Zanon, Director, European Policy and Advocacy, Alliance for Regenerative Medicine

Haiyan Zhou, Associate Professor, Genetics & Genomic Medicine Dept,, University College London

 


Get involved with Advanced Therapies Congress

 

To speak


Jessica Robinson
Jessica.Robinson@terrapinn.com
+44 208 164 3086

 

 

To sponsor or exhibit


Ashlea Foster
Ashlea.Foster@terrapinn.com
+44 208 164 3032